BVS
Bioventus Inc
13.50$
-0.6%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -157.9% | – | -32.0% | +87.3% | -200.0% | – | +16.0% | +26.1% | -76.5% | +122.4% | – | |
| – | -9.9% | -5.5% | +11.1% | -6.2% | +1.1% | -4.4% | +1.6% | -5.4% | +2.6% | -4.2% | -2.3% | – | |
| – | -3.2% | +46.0% | +123.0% | -64.3% | -16.1% | +39.5% | +50.9% | -12.8% | +8.3% | -5.1% | +54.4% | – | |
| – | – | -847.2% | – | -108.3% | – | – | – | +2,138.4% | -41.9% | -263.9% | – | – | |
| – | -81.9% | -21.1% | -73.5% | -16.9% | +796.9% | +43.9% | -17.3% | -30.7% | +22.6% | -1.0% | +67.2% | – | |
| – | -71.0% | +69.2% | -92.3% | -16.9% | – | -103.4% | +65.7% | -65.4% | +22.6% | -1.0% | +328.6% | – | |
| – | – | – | – | – | – | – | -150.0% | +283.2% | +50.1% | -23.5% | +8.0% | – | |
| – | -100.2% | +30,200.0% | +84.9% | – | -11,938.4% | – | -1,648.4% | +36.2% | +42.4% | -18.6% | +1.2% | – | |
| – | – | -216.3% | – | +62.4% | -113.5% | – | – | -8.4% | -1.9% | -269.6% | – | – | |
| – | – | -162.9% | – | -32.0% | +82.9% | -207.5% | – | +17.3% | +26.2% | -77.6% | +126.2% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.